Mokaskin - Cosmetics for Atopic Skin

This cosmetic has been clinically evaluated with outstanding results. We are seeking business partners for distribution and to continue its clinical validation to register it as a medication for the treatment of eczema and atopic dermatitis. The mode of action of its natural and patented active ingredient is to create a nourishing environment that very effectively rebalances the skin microbiome to protect it from the development of Staphylococcus aureus, the bacteria that has been associated by numerous scientific studies with the exacerbation and chronicity of atopic dermatitis/eczema. The patent for the active ingredient, a synergistic blend of plant extracts approved for cosmetic use, has already been granted in 15 countries: Indonesia, Malaysia, Australia, Vietnam, South Korea, Japan, Singapore, the United States, Brazil, Chile, Mexico, South Africa, Israel, Algeria, and Tunisia.